Cellular determinants of oxaliplatin sensitivity in colon cancer cell lines.

Arnould, S; Hennebelle, I; Canal, P; Bugat, R; Guichard, S

Arnould, S; Hennebelle, I; Canal, P; Bugat, R; Guichard, S.

Affiliation

Arnould S; Groupe de Pharmacologie clinique et expérimentale (EA 3035), Institut Claudius Regaud, 20-24, rue du pont St Pierre, 31052 cedex, Toulouse, France.

Eur J Cancer ; 39(1): 112-9, 2003 Jan.

Article in En | MEDLINE | ID: mdl-12504667

Subject(s)

Antineoplastic Agents/therapeutic use; Cisplatin/therapeutic use; Colonic Neoplasms/drug therapy; Organoplatinum Compounds/therapeutic use; Colonic Neoplasms/enzymology; DNA Adducts/metabolism; DNA, Neoplasm/metabolism; Glutathione/metabolism; Glutathione Transferase/metabolism; Humans; Lethal Dose 50; Oxaliplatin; RNA, Messenger/metabolism; Reverse Transcriptase Polymerase Chain Reaction/methods; Tumor Cells, Cultured/drug effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Organoplatinum Compounds / Cisplatin / Colonic Neoplasms / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Eur J Cancer Year: 2003 Type: Article Affiliation country: France

Search on Google

XML

PubMed Links